What is Cytek Biosciences, Inc.'s net income?

Cytek Biosciences, Inc. (CTKB) reported net income of -$18.87M in Q1 2026.

How has Cytek Biosciences, Inc.'s net income changed year-over-year?

Cytek Biosciences, Inc.'s net income decreased by 65.5% year-over-year, from -$11.4M to -$18.87M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Cytek Biosciences, Inc. CTKB Net Income

Net Income at other companies

Becton, Dickinson and CompanyBDX

-$311M-201%

Thermo Fisher ScientificTMO

$1.65B+9.6%

DanaherDHR

$1.03B+7.9%

Fulgent Genetics, Inc.FLGT

-$24.83M-115%

10x Genomics, Inc.TXG

-$13.47M+60.8%

TEC

Bio-TechneTECH

$51.05M+126%

Segments

By segment

See full

Reportable Segment-$18.87M-65.5%

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s net income?: Cytek Biosciences, Inc. (CTKB) reported net income of -$18.87M in Q1 2026.
How has Cytek Biosciences, Inc.'s net income changed year-over-year?: Cytek Biosciences, Inc.'s net income decreased by 65.5% year-over-year, from -$11.4M to -$18.87M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.